Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

The need for randomization in animal trials: an overview of systematic reviews.
'It feels like someone is hammering my feet': Understanding pain and its management from the perspective of people with multiple sclerosis.
The secretome of mesenchymal stem cells: Potential implications for neuroregeneration.
The gateway theory: bridging neural and immune interactions in the CNS.
Sera from patients with seropositive neuromyelitis optica spectral disorders caused the degeneration of rodent optic nerve.
B7-H1 Selectively Controls TH17 Differentiation and Central Nervous System Autoimmunity via a Novel Non-PD-1-Mediated Pathway.
Brugada sign in a multiple sclerosis patient: Relation to autonomic nervous system dysfunction and therapeutic dilemmas.
Activation of microglial P2Y12 receptor is required for outward potassium currents in response to neuronal injury.
MerTK Is a Functional Regulator of Myelin Phagocytosis by Human Myeloid Cells.
Endocannabinoids and Endocannabinoid-Related Mediators: Targets, Metabolism and Role In Neurological Disorders.
Lesion filling effect in regional brain volume estimations: a study in multiple sclerosis patients with low lesion load.
Extracellular vesicles round off communication in the nervous system.
Is customized vestibular rehabilitation effective in patients with multiple sclerosis? A randomized controlled trial.
Paucity of natural killer and cytotoxic T cells in human neuromyelitis optica lesions.
Progress in multiple sclerosis genetics.
On the role of physiological fluctuations in quantitative gradient echo MRI: implications for GEPCI, QSM, and SWI.
Psychiatric diagnoses, medication and risk for disability pension in multiple sclerosis patients; a population-based register study.
Differential Pro-Inflammatory Responses of Astrocytes and Microglia Involve STAT3 Activation in Response to 1800 MHz Radiofrequency Fields.
Positive or negative involvement of heat shock proteins in multiple sclerosis pathogenesis: an overview.
[Two new oral disease modifying therapies in relapsing remitting multiple sclerosis].
A prospective observational post-marketing study of natalizumab-treated multiple sclerosis patients: clinical, radiological and biological features and adverse events. The BIONAT cohort.
Current and new directions in MRI in multiple sclerosis.
Which is the goal of cognitive rehabilitation in multiple sclerosis: the improvement of cognitive performance or the perception of cognitive deficits?
Myelin architecture: zippering membranes tightly together.
Neurophysiological Evidence of Compensatory Brain Mechanisms in Early-Stage Multiple Sclerosis.

Pages